History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
about
Italian guidelines for primary headaches: 2012 revised versionAn update on the blood vessel in migraineWhere is dihydroergotamine mesylate in the changing landscape of migraine therapy?One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.Correlation of visual field defects and optical coherence tomography finding in migraine patientsAdverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies.Ischemic colitis secondary to ergotamine use: a case studyIncreased Brainstem Serotonergic Transporter Availability in Adult Migraineurs: an [(18)F]FP-CIT PET Imaging Pilot StudyMigraine pain: reflections against vasodilatation.Dihydroergotamine: role in the treatment of migraine.What happens to the old headache medicines?MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine.The pathophysiological and pharmacological basis of current drug treatment of migraine headache.Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs.Use of dihydroergotamine (DHE) should be restricted to no more than twice a week.Pharmacological treatment of chronic non-cancer pain in pediatric patients.The qualitative problem of major quotation errors, as illustrated by 10 different examples in the headache literature.Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse.Medication overuse and chronic migraine: a critical review according to clinical pharmacology.Holy fire in an HIV-positive man: a case of 21st-century ergotism.Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand.Overview of migraine treatment.Dysautonomia in the pathogenesis of migraine.Ergotamine Use and Overuse in Taiwan: A Retrospective Cohort Study.The history of oxygen inhalation as a treatment for cluster headache.Targeted 5-HT1F Therapies for Migraine.Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.Vascular Contributions to Migraine: Time to Revisit?
P2860
Q30466790-A8A16BE3-0461-4860-879C-4B637AAD6B65Q33880507-360EC55A-272E-4EBF-94C4-F37176E0CA8CQ34150104-73548FBE-4C0A-41F3-97FB-87354AD2527BQ34180539-F7447020-EE1D-4A46-AE03-906A9B6610C6Q35040610-007B55EB-E57F-4366-86E3-0A76F6F6C484Q35270090-349D8034-5770-46E2-86A1-37E1527A563CQ35759798-005FDF84-3612-4715-B938-4A4A0520F398Q36604980-CC4B465E-00B8-4076-AD85-CCA4AE9ABD7CQ37508771-73E3AE14-AD2F-4CA9-BBC0-D445A93CBDA3Q37558538-AA682C89-E4E3-45B1-A886-74068267BDDDQ38001056-A6CADCBC-7310-473A-AAC4-FB9DD5F2CF42Q38031885-1E68925F-AB1F-4610-B4C7-F446D4EC5CBBQ38105147-8525985F-9016-43F6-8944-62C79164A5DEQ38167355-0C959E10-6100-40AB-8EF6-AF693099E75FQ38215048-5C00470F-F434-4390-8B10-B4EF0DE991BCQ38258949-C2794E46-8D50-4396-9956-C165A03322C2Q38373700-5DA7DC19-A641-4707-9D3D-8599D95D3726Q38476100-0E77D52A-9590-487E-9E63-83B0185FCD38Q38509398-FF3C9BF1-5CB6-4C1D-93E2-5AF77219D92DQ39387540-BE307A02-A78A-4657-B705-93B96748E956Q45892542-EEBEAB11-C535-42DD-834B-319A34757A4CQ46098987-1E6E9C98-4A53-4879-B921-2D233A9AC202Q47656535-A4533C28-BCB4-4744-98E7-A70DC1C61AF6Q48249123-587A039B-D3C3-4F94-8835-4016EC7B69AEQ48419334-AD706930-33C4-4DB9-9FBD-382662E5003EQ52682101-EDF7E9CB-0038-4530-86E2-7BC433FEA364Q55296093-6D634A96-C204-4B15-88EF-0B885619F0D4Q58801458-43B71B05-B302-43D4-B438-116E3BCAB491
P2860
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
@en
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
@nl
type
label
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
@en
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
@nl
prefLabel
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
@en
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
@nl
P2860
P1433
P1476
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
@en
P2093
P C Tfelt-Hansen
P J Koehler
P2860
P304
P356
10.1111/J.1468-2982.2008.01578.X
P407
P577
2008-05-05T00:00:00Z